Alzheimer Disease

Citations 101-110 of 489 total displayed.

Past content (since Jan 1998):

Original Contributions
Three-Dimensional Gray Matter Atrophy Mapping in Mild Cognitive Impairment and Mild Alzheimer Disease

Liana G. Apostolova; Calen A. Steiner; Gohar G. Akopyan; Rebecca A. Dutton; Kiralee M. Hayashi; Arthur W. Toga; Jeffrey L. Cummings; Paul M. Thompson
Arch Neurol 2007; 64: 1489-1495. [Abstract] [Full text] [PDF]  

Observations
Familial Early-Onset Dementia With Tau Intron 10 + 16 Mutation With Clinical Features Similar to Those of Alzheimer Disease

Mark Doran; Daniel G. du Plessis; Eric J. Ghadiali; David M. A. Mann; Stuart Pickering-Brown; Andrew J. Larner
Arch Neurol 2007; 64: 1535-1539. [Abstract] [Full text] [PDF]  

Corrections
Error in Text in: Association of Low Plasma A42/A40 Ratios With Increased Imminent Risk for Mild Cognitive Impairment and Alzheimer Disease

Arch Neurol 2007; 64: 1246. [Full text] [PDF]  

Original Contributions
Cognitive Domain Decline in Healthy Apolipoprotein E 4 Homozygotes Before the Diagnosis of Mild Cognitive Impairment

Richard J. Caselli; Eric M. Reiman; Dona E. C. Locke; Michael L. Hutton; Joseph G. Hentz; Charlene Hoffman-Snyder; Bryan K. Woodruff; Gene E. Alexander; David Osborne
Arch Neurol 2007; 64: 1306-1311. [Abstract] [Full text] [PDF]  

Original Contributions
Superior Frontal Cortex Cholinergic Axon Density in Mild Cognitive Impairment and Early Alzheimer Disease

Milos D. Ikonomovic; Eric E. Abrahamson; Barbara A. Isanski; Joanne Wuu; Elliott J. Mufson; Steven T. DeKosky
Arch Neurol 2007; 64: 1312-1317. [Abstract] [Full text] [PDF]  

Original Contributions
A Neuropsychological Test Battery for Use in Alzheimer Disease Clinical Trials

John Harrison; Sonia L. Minassian; Lisa Jenkins; Ronald S. Black; Martin Koller; Michael Grundman
Arch Neurol 2007; 64: 1323-1329. [Abstract] [Full text] [PDF] [ Notice of Failure to Disclose Financial Interest ]  

Correspondence
Biomarkers in Dementia

Nicola Vanacore; Francesca Galeotti; Marina Maggini; Roberto Raschetti
Arch Neurol 2007; 64: 1356. [Extract] [Full text] [PDF]  

Correspondence
Medication Use as a Confounding Factor in the Use of the Cerebrospinal Fluid tau/-Amyloid₄₂ Ratio—Reply

Anne M. Fagan; Catherine M. Roe; Chengjie Xiong; Mark A. Mintun; John C. Morris; David M. Holtzman
Arch Neurol 2007; 64: 1357-a-1359-a. [Extract] [Full text] [PDF]  

Correspondence
Medication Use as a Confounding Factor in the Use of the Cerebrospinal Fluid tau/-Amyloid₄₂ Ratio

Victoria Wong
Arch Neurol 2007; 64: 1357. [Extract] [Full text] [PDF]  

Original Contributions
Patterns of Atrophy Differ Among Specific Subtypes of Mild Cognitive Impairment

Jennifer L. Whitwell; Ronald C. Petersen; Selamawit Negash; Stephen D. Weigand; Kejal Kantarci; Robert J. Ivnik; David S. Knopman; Bradley F. Boeve; Glenn E. Smith; Clifford R. Jack Jr
Arch Neurol 2007; 64: 1130-1138. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49